Gateway Investment Advisers LLC Abb Vie Inc. Transaction History

Gateway Investment Advisers LLC

  • $9 Billion
  • Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 439,281 shares of ABBV stock, worth $77.4 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
439,281
Previous 439,560 0.06%
Holding current value
$77.4 Million
Previous $75.4 Million 15.06%
% of portfolio
0.96%
Previous 0.86%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
SELL
$163.84 - $199.33 $45,711 - $55,613
-279 Reduced 0.06%
439,281 $86.7 Million
Q2 2024

Jul 12, 2024
SELL
$154.79 - $180.76 $292,862 - $341,997
-1,892 Reduced 0.43%
439,560 $75.4 Million
Q1 2024

Apr 12, 2024
SELL
$159.82 - $182.1 $5.27 Million - $6.01 Million
-32,998 Reduced 6.96%
441,452 $80.4 Million
Q4 2023

Jan 09, 2024
SELL
$137.6 - $154.97 $50,086 - $56,409
-364 Reduced 0.08%
474,450 $73.5 Million
Q3 2023

Oct 19, 2023
SELL
$133.59 - $154.65 $148,685 - $172,125
-1,113 Reduced 0.23%
474,814 $70.8 Million
Q2 2023

Jul 13, 2023
SELL
$132.51 - $164.9 $123,896 - $154,181
-935 Reduced 0.2%
475,927 $64.1 Million
Q1 2023

Apr 11, 2023
SELL
$144.61 - $166.54 $1.56 Million - $1.8 Million
-10,784 Reduced 2.21%
476,862 $76 Million
Q4 2022

Jan 13, 2023
SELL
$138.31 - $165.87 $3.91 Million - $4.69 Million
-28,295 Reduced 5.48%
487,646 $0
Q3 2022

Oct 07, 2022
SELL
$134.21 - $153.93 $4.05 Million - $4.65 Million
-30,197 Reduced 5.53%
515,941 $69.2 Million
Q2 2022

Jul 13, 2022
BUY
$137.62 - $174.96 $2.94 Million - $3.73 Million
21,345 Added 4.07%
546,138 $83.6 Million
Q1 2022

Apr 14, 2022
SELL
$131.98 - $163.75 $3.3 Million - $4.09 Million
-25,000 Reduced 4.55%
524,793 $85.1 Million
Q4 2021

Jan 14, 2022
SELL
$107.43 - $135.93 $3.26 Million - $4.12 Million
-30,337 Reduced 5.23%
549,793 $74.4 Million
Q3 2021

Oct 22, 2021
SELL
$106.4 - $120.78 $2.64 Million - $3 Million
-24,806 Reduced 4.1%
580,130 $62.6 Million
Q2 2021

Jul 13, 2021
SELL
$105.21 - $117.21 $432,623 - $481,967
-4,112 Reduced 0.68%
604,936 $68.1 Million
Q1 2021

Apr 14, 2021
SELL
$102.3 - $112.62 $1.98 Million - $2.18 Million
-19,398 Reduced 3.09%
609,048 $65.9 Million
Q4 2020

Jan 14, 2021
SELL
$80.49 - $108.67 $2.75 Million - $3.72 Million
-34,221 Reduced 5.16%
628,446 $67.3 Million
Q3 2020

Oct 19, 2020
SELL
$85.91 - $100.83 $114,603 - $134,507
-1,334 Reduced 0.2%
662,667 $58 Million
Q2 2020

Jul 15, 2020
SELL
$73.37 - $98.18 $6.02 Million - $8.06 Million
-82,051 Reduced 11.0%
664,001 $65.2 Million
Q1 2020

Apr 13, 2020
BUY
$64.5 - $97.79 $7.37 Million - $11.2 Million
114,212 Added 18.08%
746,052 $56.8 Million
Q4 2019

Jan 09, 2020
SELL
$72.13 - $90.25 $922,109 - $1.15 Million
-12,784 Reduced 1.98%
631,840 $55.9 Million
Q3 2019

Oct 15, 2019
SELL
$62.98 - $75.72 $2.83 Million - $3.4 Million
-44,924 Reduced 6.51%
644,624 $48.8 Million
Q2 2019

Jul 17, 2019
SELL
$65.7 - $83.98 $5.61 Million - $7.17 Million
-85,382 Reduced 11.02%
689,548 $50.1 Million
Q1 2019

Apr 10, 2019
SELL
$77.14 - $90.79 $2.65 Million - $3.11 Million
-34,309 Reduced 4.24%
774,930 $62.5 Million
Q4 2018

Jan 14, 2019
BUY
$77.85 - $96.01 $93,887 - $115,788
1,206 Added 0.15%
809,239 $74.6 Million
Q3 2018

Oct 16, 2018
SELL
$88.91 - $98.84 $1.23 Million - $1.37 Million
-13,856 Reduced 1.69%
808,033 $76.4 Million
Q2 2018

Jul 11, 2018
SELL
$89.78 - $106.23 $4.43 Million - $5.24 Million
-49,343 Reduced 5.66%
821,889 $76.1 Million
Q1 2018

Apr 12, 2018
SELL
$92.01 - $123.21 $1.03 Million - $1.38 Million
-11,229 Reduced 1.27%
871,232 $82.5 Million
Q4 2017

Jan 17, 2018
SELL
$89.56 - $98.21 $3.39 Million - $3.71 Million
-37,804 Reduced 4.11%
882,461 $85.3 Million
Q3 2017

Oct 16, 2017
BUY
$69.85 - $89.22 $64.3 Million - $82.1 Million
920,265
920,265 $81.8 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $312B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email